|
Mr. Stephen Globus is a director of China Biopharmaceutical Holdings (CBH). Mr. Globus was previously the Chairman of Globus Growth Group, a venture capital group for technology companies. Under his management, Globus Growth Group made strategic seed investments in a number of companies such as Plasmaco , a USA manufacturer of plasma TV which was later acquired by Matsushita (Panasonic); Genitope, a San Francisco based biotechnology company in the field of immune-therapies; Proscure , a Boston based biotechnology company which was later acquired by Repligen (RGEN); Kimeragen , a gene modification company which was later acquired by Valigen .Other early investments of Globus Growth Group are in FuelCell Energy (FCEL) and ExSar . Mr. Globus mainly resides in New York City. | 